Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery
Analgesia, Breast Cancer
About this trial
This is an interventional prevention trial for Analgesia
Eligibility Criteria
Inclusion Criteria:
- Age of 18 - 60 years.
- ASA grade I - II.
Exclusion Criteria:
- Patient refusal. known allergy to the study drugs skin infection at site of needle puncture significant organ dysfunction Coagulopathy drug or alcohol abuse psychiatric illness that would interfere with perception and assessment of pain.
Sites / Locations
- south Egypt Cancer Institute Assiut University
Arms of the Study
Arm 1
Arm 2
Arm 3
Placebo Comparator
Experimental
Experimental
Group (C) (control group)
Group (K) (Ketamine group)
Group (M) (magnesium sulphate group)
Patient will receive 10 ml 0.25% levobupivacaine into interfascial plane below erector spinae muscle at level of T5 and 10 ml at level of T7.
Patient will receive 10 ml 0.25% levobupivacaine into interfascial plane below erector spinae muscle at level of T5 and 10 ml at level of T7+ 1 mg / kg ketamine at each level with total dose 2mg/kg
Patient will receive 10 ml 0.25% levobupivacaine into interfascial plane below erector spinae muscle at level of T5 and 10 ml at level of T7+ 1 mg / kg MgSo4 at each level with total dose 2mg/kg